Transcriptomics and machine learning predict diagnosis and severity of growth hormone deficiency.

Journal: JCI insight
PMID:

Abstract

BACKGROUND: The effect of gene expression data on diagnosis remains limited. Here, we show how diagnosis and classification of growth hormone deficiency (GHD) can be achieved from a single blood sample using a combination of transcriptomics and random forest analysis.

Authors

  • Philip G Murray
    Division of Developmental Biology and Medicine, Faculty of Biology, Medicine and Health, University of Manchester and Manchester Academic Health Science Centre, Manchester, United Kingdom.
  • Adam Stevens
    Division of Developmental Biology and Medicine, Faculty of Biology, Medicine and Health, University of Manchester and Manchester Academic Health Science Centre, Manchester, United Kingdom.
  • Chiara De Leonibus
    Division of Developmental Biology and Medicine, Faculty of Biology, Medicine and Health, University of Manchester and Manchester Academic Health Science Centre, Manchester, United Kingdom.
  • Ekaterina Koledova
    Global Medical Affairs Endocrinology, Global Medical, Safety & CMO Office, Merck KGaA, Darmstadt, Germany.
  • Pierre Chatelain
    Department Pediatrie, Hôpital Mère-Enfant - Université Claude Bernard, Lyon, France.
  • Peter E Clayton
    Division of Developmental Biology and Medicine, Faculty of Biology, Medicine and Health, University of Manchester and Manchester Academic Health Science Centre, Manchester, United Kingdom.